Sort   by:  
 Page size 
Adeno-associated virus (AAV) has emerged as a leading platform for gene therapy. With a skyrocketing rate of AAV research and the prevalence of many new engineered capsids being investigated in preclinical and clinical trials, capsid characterization plays an important role in serotype confirmation ...
ORGANISM(S): Adeno-associated virus 9 
2023-03-11 | PXD035837 | Pride
AAV Assembled Capsids Are Produced in Cells Blocked fromFrom Cell Cycle Progression
CD-MS analysis collected on an Orbitrap UHMR. Note, this data was collected on a beta version of the DMT software and thus contains STORI files stored in separate zip files. The DMT files are also included as supplemental files, along with the UniDecCD processing parameters.
ORGANISM(S): Adeno-associated Dependoparvovirus A (ncbitaxon:1511891) 
2023-04-05 | MSV000091650 | MassIVE
Adeno-associated virus (AAV) is a promising delivery system for gene therapy. However, current manufacturing of AAV suffers from very low yields compared to other biotherapeutics. The AAV dose per patient ranges between 1011and 1015 viral genomes (vg), requiring an average of 10 to 30 L production/d...
ORGANISM(S): Homo sapiens 
2025-11-21 | GSE276141 | GEO
IP-MS analysis of AAV9 empty capsid protein-protein interactions with serum from healthy human donors.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2023-03-09 | MSV000091454 | MassIVE
AAV is widely used for efficient delivery of DNA payloads. The extent to which the AAV capsid can be used to deliver a protein payload is unexplored. Here, we report engineered AAV capsids that directly package proteins – Protein Carrier AAV (pcAAV). Nanobodies inserted into the interior of the caps...
ORGANISM(S): Adeno-associated virus 2 Srivastava/1982 
2025-05-07 | PXD054767 | Pride
Sort   by:  
 Page size